At close: January 3 at 4:00:01 PM EST
After hours: January 3 at 4:00:12 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 2 | 3 | 3 |
| Avg. Estimate | 0.26 | 0.21 | 0.59 | 0.76 |
| Low Estimate | 0.25 | 0.14 | 0.58 | 0.66 |
| High Estimate | 0.28 | 0.28 | 0.61 | 0.82 |
| Year Ago EPS | 0.21 | 0.08 | 0.7 | 0.59 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 3 | 3 |
| Avg. Estimate | 113.66M | 118.96M | 452.52M | 458.16M |
| Low Estimate | 113.4M | 118.96M | 451.6M | 456.9M |
| High Estimate | 113.93M | 118.96M | 453.8M | 459.07M |
| Year Ago Sales | 213.52M | 118.19M | 866.72M | 452.52M |
| Sales Growth (year/est) | -46.77% | 0.65% | -47.79% | 1.25% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.12 | -0.04 | 0.17 | 0.09 |
| EPS Actual | 0.21 | 0.08 | 0.13 | 0.12 |
| Difference | 0.09 | 0.12 | -0.04 | 0.03 |
| Surprise % | 68.67% | 292.77% | -24.86% | 26.98% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.26 | 0.21 | 0.59 | 0.76 |
| 7 Days Ago | 0.26 | 0.14 | 0.59 | 0.74 |
| 30 Days Ago | 0.26 | 0.14 | 0.59 | 0.74 |
| 60 Days Ago | 0.25 | 0.14 | 0.58 | 0.74 |
| 90 Days Ago | 0.25 | 0.14 | 0.58 | 0.74 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | -- | -- | -- |
| Up Last 30 Days | 1 | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | 1 | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ZIMV | 24.53% | 161.56% | -15.29% | 27.54% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Maintains | Needham: Buy to Buy | 8/2/2024 |
| Reiterates | Needham: Buy to Buy | 6/25/2024 |
| Upgrade | Needham: Hold to Buy | 5/16/2024 |
| Reiterates | Needham: Hold | 5/9/2024 |
| Reiterates | Needham: Hold | 4/11/2024 |
| Maintains | Barclays: Underweight to Underweight | 3/5/2024 |
Related Tickers
ZBH Zimmer Biomet Holdings, Inc.
104.47
+0.01%
AVNS Avanos Medical, Inc.
15.55
-1.77%
KIDS OrthoPediatrics Corp.
23.35
+2.10%
SNN Smith & Nephew plc
24.42
+0.08%
ZIM.F Zimmer Biomet Holdings, Inc.
101.35
-0.34%
2M6.DE Medtronic plc
78.06
-0.19%
LUNG Pulmonx Corporation
6.55
+0.46%
INGN Inogen, Inc.
9.62
+4.68%
SNWV SANUWAVE Health, Inc.
22.01
+0.05%
SGHT Sight Sciences, Inc.
3.4900
-2.51%